ACADIA Pharmaceuticals Inc (ACAD)
45.75
-1.15 -2.45%
NASDAQ
Jun 4, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 366.18M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.58 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -237.98M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 94.48% |
| Profit Margin (Quarterly) | -97.73% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 7.131B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 18.75 |
| PE Ratio | -- |
| Price to Book Value | 11.17 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -49.94M |
| Return on Equity | Upgrade |
View All ACAD News
News
-
WireHeadlineTime (ET)
-
Business Wire06/02 09:00
-
Yahoo06/02 07:27
-
Business Wire05/28 09:00
-
Yahoo05/27 12:15
-
MT Newswires05/27 11:37
-
MT Newswires05/26 10:48
-
Business Wire05/26 09:00
-
Yahoo05/21 23:28
-
Business Wire05/21 09:00
-
Yahoo05/09 08:02
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 07/31/2020 16:30 EDT | Misc | ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2020 |
| 07/31/2020 | Earnings | ACADIA Pharmaceuticals Inc Second Quarter Earnings in 2020 Release |
| 06/23/2020 08:00 PDT | Misc | ACADIA Pharmaceuticals Inc Annual General Meeting for 2019 |
| 05/07/2020 16:30 EDT | Misc | ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 05/07/2020 | Earnings | ACADIA Pharmaceuticals Inc First Quarter Earnings Result for 2020 |
| 02/27/2020 | Misc | ACADIA Pharmaceuticals Inc Annual Report for 2019 |
| 02/26/2020 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
| 02/26/2020 | Earnings | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release |
| 10/30/2019 16:30 EDT | Misc | ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019 |
| 10/30/2019 | Earnings | ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.acadia-pharm.com
- Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Jul. 31, 2020
- Last Earnings Release: May. 07, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 45.75 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ASYMX | Alger Weatherbie Specialized Growth Y | 3.20% |
| PTH | Invesco DWA Healthcare Momentum ETF | 2.36% |
| XBI | SPDR® S&P Biotech ETF | 1.71% |
| CEARX | Columbia Acorn Adv | 1.43% |
| FBIOX | Fidelity® Select Biotechnology | 1.36% |
| FGKFX | Fidelity® Growth Company K6 | 0.91% |
| FCGSX | Fidelity® Series Growth Company | 0.91% |
| FGCKX | Fidelity® Growth Company K | 0.89% |
| HQH | Tekla Healthcare Investors | 0.84% |
| IBB | iShares Nasdaq Biotechnology ETF | 0.80% |
| IWO | iShares Russell 2000 Growth ETF | 0.51% |
| IWM | iShares Russell 2000 ETF | 0.29% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ACAD Tweets Stocktwits
Advertisement
